YD Bio (YDESW) Assets (2024 - 2026)

YD Bio (YDESW) has reported Assets for 3 consecutive years, with $10.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets rose 72.23% year-over-year to $10.1 million in Q2 2026; TTM through Jun 2026 was $10.1 million, a 72.23% increase from a year earlier, with the FY2025 full-year figure at $13.8 million, up 100.74% from the prior year.
• Assets was $10.1 million for Q2 2026 at YD Bio, down from $13.8 million in the prior quarter.
• Over five years, Assets peaked at $13.8 million in Q4 2025 and troughed at $5.8 million in Q2 2025.
• A 3-year average of $9.1 million and a median of $8.5 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets surged 100.74% in 2025 and surged 72.23% in 2026, its largest moves.
• Over 3 years, Assets stood at $6.9 million in 2024, then surged by 100.74% to $13.8 million in 2025, then declined by 26.99% to $10.1 million in 2026.
• The last three Assets figures came in at $10.1 million (Q2 2026), $13.8 million (Q4 2025), and $5.8 million (Q2 2025), per Business Quant data.